SCHEMBL4843178

SCHEMBL4843178

CCN(C(=O)C(C(C(=O)O)C(C)(C)C)C(C(=O)O)C(C)(C)C)c1ccc2ccccc2c1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
PPARG P37231 3/20 0.39
PPARA Q07869 3/20 0.39
MAPK14 Q16539 2/20 0.39
GLA P06280 1/20 0.38
TSHR P16473 1/20 0.38
OXTR P30559 1/20 0.37
CNR2 P34972 1/20 0.36
MLYCD O95822 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
MET P08581 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4838671 0.76 ALDH1A1 (0.41) ALDH1A1MEN1KMT2ASMN1; SMN2PPARG
SCHEMBL15708137 0.74 ALDH1A1 (0.47) ALDH1A1MEN1KMT2ASMN1; SMN2PPARG
SCHEMBL3797212 0.73 SMN1; SMN2 (0.49) ALDH1A1MEN1KMT2ASMN1; SMN2MAPK14
SCHEMBL27605169 0.72 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MAPK14GLATSHR
SCHEMBL9547593 0.71 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2MAPK14GLATSHR
SCHEMBL3239999 0.70 OXTR (0.48) ALDH1A1MEN1KMT2ASMN1; SMN2PPARG
SCHEMBL3103221 0.68 CYP1A2 (0.45) ALDH1A1SMN1; SMN2PPARGPPARAGLA
SCHEMBL13430558 0.67 ALDH1A1 (0.47) ALDH1A1MEN1KMT2ASMN1; SMN2MAPK14
SCHEMBL7102909 0.65 PTPN7 (0.42) ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL28393290 0.65 ALDH1A1 (0.41) ALDH1A1MEN1KMT2ASMN1; SMN2PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365091-B2 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX ENOBIA PHARMA (CA) 2008-04-29 US disclosed
US-20060287280-A1 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX ENOBIA PHARMA (CA) 2006-12-21 US disclosed
US-7105539-B2 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex ENOBIA PHARMA (CA) 2006-09-12 US disclosed
US-20060135480-A1 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex ENOBIA PHARMA (CA) 2006-06-22 US disclosed
US-20040186301-A1 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex BIOMEP INC. 2004-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287280-A1 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX GLS, SUCNR1, PGD ALDH1A1 1377/4885MEN1 876/4885KMT2A 2453/4885
US-20040186301-A1 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex GLS, SUCNR1, PGD ALDH1A1 1271/4885MEN1 923/4885KMT2A 2577/4885
US-20060135480-A1 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex GLS, SUCNR1, GCDH ALDH1A1 1091/4885MEN1 937/4885KMT2A 2487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.